Aucta is a global brand that creates better products from proven molecules.
Reset all filters
01 1Aucta Pharmaceuticals
02 1Acme Lifetech
03 1Aeron Remedies
04 4Aurobindo Pharma Limited
05 2Caristar Laboratories
06 2Delius Pharmaceuticals
07 2Dycine Pharma
08 1Halewood Laboratories Pvt. Ltd
09 1Hanlim Pharmaceuticals Inc
10 3LAB.GUIDOTTI SpA
11 1Myungmoon Pharm. Co., LTD.
12 5PTC Therapeutics
13 4Sun Pharmaceutical Industries Limited
14 2Swasthya Healthcare
15 3TEOFARMA Srl
16 1Themis Medicare
17 1Tris Pharma Inc
18 1Unicor Pharmatech
19 4Upsher-Smith Laboratories
20 1Vaishali Pharma Ltd
21 1Vega Biotech Pvt. Ltd.
22 5ZRS LABS
23 1Zota Healthcare Ltd
24 4Zydus Lifesciences
25 26Blank
Reset all filters
01 2Oral Suspension
02 3SUSPENSION;ORAL
03 1Syrup
04 5TABLET
05 20TABLET;ORAL
06 41Tablet
07 6Blank
Reset all filters
01 4Generic
02 1Generic B.E study
03 23RX
04 50Blank
Reset all filters
01 1CORTOSEPT-30
02 1CORTOSEPT-6
03 1Cerdef
04 1DEFLA
05 13DEFLAZACORT
06 3Deflan
07 1Deflazacort Alter 30Mg 10 Tablets Efg
08 1Deflazacort Alter 6Mg 20 Tablets Efg
09 1Deflazacort Cinfa 30Mg 10 Tablets Efg
10 1Deflazacort Cinfa 6Mg 20 Tablets Efg
11 1Deflazacort Kern Pharma 30Mg 10 Tablets Efg
12 1Deflazacort Kern Pharma 6Mg 20 Tablets Efg
13 1Deflazacort Normon 30Mg 10 Tablets Efg
14 1Deflazacort Normon 6Mg 20 Tablets Efg
15 1Deflazacort Pensa 30Mg 10 Tablets Efg
16 1Deflazacort Pensa 6Mg 20 Tablets Efg
17 1Deflazacort Ranbaxy 30Mg 10 Tablets Efg
18 1Deflazacort Sandoz 30Mg 10 Comprimdidos Efg
19 1Deflazacort Sandoz 6Mg 20 Tablets Efg
20 1Deflazacort Stada 30Mg 10 Tablets Efg
21 1Deflazacort Stada 6Mg 20 Tablets Efg
22 1Deflazacort Tarbis 30Mg 10 Tablets Efg
23 1Deflazacort Veris 30Mg 10 Tablets Efg
24 1Deflazacort Veris 6Mg 20 Tablets Efg
25 1Deflazacort Vir 30Mg 10 Tablets Efg
26 1Deflazacort Vir 6Mg 20 Tablets Efg
27 2Delflaz 6
28 1Dezacor 22,75Mg/Ml 13Ml 1 Bottle Suspension Drops
29 1Dezacor 30Mg 10 Tablets
30 1Dezacor 6Mg 20 Tablets
31 5EMFLAZA
32 1FLAZARON 6
33 3Flantadin
34 1Inflacort
35 4JAYTHARI
36 1PYQUVI
37 1Telacort
38 1Zamene 30Mg 10 Tablets
39 1Zamene 6Mg 20 Tablets
40 1Zamene Drops 22.75Mg/Ml Suspension Drops
41 14Blank
Reset all filters
01 21India
02 6Italy
03 2South Korea
04 26Spain
05 23USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PYQUVI
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 22.75MG/ML
Packaging :
Approval Date : 2025-06-30
Application Number : 219417
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 36MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 36MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 22.75MG/ML
Packaging :
Approval Date : 2017-02-09
Application Number : 208685
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2025-03-18
Application Number : 217741
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2025-03-18
Application Number : 217741
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2025-03-18
Application Number : 217741
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 36MG
Packaging :
Approval Date : 2025-03-18
Application Number : 217741
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 22.75MG/ML
Packaging :
Approval Date : 2024-04-25
Application Number : 217813
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 36MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAYTHARI
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2025-04-08
Application Number : 219254
Regulatory Info : RX
Registration Country : USA